Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
lipiodol + peptide
- Development stage
- Unknown
- Lead developer
- Guerbet
- Modality
- Hydrogel Systems → Drug Delivery Systems, Peptides, Small Molecules
- Administration
- Intra-arterial
01
Overview
Lipiodol + peptide refers to a specialized Pickering emulsion formulation used in transarterial chemoembolization (TACE) for the treatment of unresectable hepatocellular carcinoma (HCC). The formulation consists of Lipiodol (ethiodized oil) mixed with a hydrophilic chemotherapy solution (containing agents such as doxorubicin, mitoxantrone, or oxaliplatin) and stabilized by Peptuxen, a temperature-sensitive peptide hydrogel. This ultra-stable emulsion is designed to improve the local concentration and retention of chemotherapy within the tumor while providing effective arterial embolization. Developed by the Bishan District People's Hospital, this therapeutic approach is currently being evaluated in Phase 0 clinical trials, often in combination with intratumoral immunotherapy to enhance the anti-tumor immune response.
- Brand names
- Peptuxen
- Other names
- lipiodol-peptide emulsionPeptuxen-stabilized Pickering emulsionlipiodol-peptide emulsion TACE
02
Targets
TOP2A (DNA topoisomerase II)DNA
Beyond the preview
Go deeper on lipiodol + peptide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on lipiodol + peptide.